CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 74 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $18,000 | -18.2% | 107,299 | +25.4% | 0.00% | – |
| Q2 2022 | $22,000 | -4.3% | 85,592 | +101.6% | 0.00% | – |
| Q1 2022 | $23,000 | +53.3% | 42,453 | +74.1% | 0.00% | – |
| Q4 2021 | $15,000 | -34.8% | 24,384 | +5.9% | 0.00% | – |
| Q3 2021 | $23,000 | 0.0% | 23,035 | +81.5% | 0.00% | – |
| Q2 2021 | $23,000 | -8.0% | 12,691 | +0.6% | 0.00% | – |
| Q1 2021 | $25,000 | -10.7% | 12,619 | -44.5% | 0.00% | – |
| Q4 2020 | $28,000 | -66.3% | 22,738 | -50.4% | 0.00% | – |
| Q3 2020 | $83,000 | -56.1% | 45,867 | +103.6% | 0.00% | – |
| Q2 2020 | $189,000 | +47.7% | 22,528 | -7.3% | 0.00% | – |
| Q1 2020 | $128,000 | – | 24,299 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |